<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02441413</url>
  </required_header>
  <id_info>
    <org_study_id>FLUI-2014-103_BE</org_study_id>
    <nct_id>NCT02441413</nct_id>
  </id_info>
  <brief_title>Transplant Optimization Using Functional Imaging (TROFI)</brief_title>
  <acronym>TROFI_BE</acronym>
  <official_title>Transplant Optimization Using Functional Imaging (TROFI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>FLUIDDA nv</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FLUIDDA nv</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to detect Bronchiolitis Obliterans Syndrome (BOS) in an early
      stage using the outcome parameters generated by Functional Respiratory Imaging (FRI). Robust
      and automated segmentation algorithms will be developed for these parameters, focusing on
      quantitative computed tomography (CT) image analyses to provide the physician a more
      sensitive diagnostics tool. The evolution of BOS over time will be monitored using nmon-rigid
      image registration methods.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">November 8, 2016</completion_date>
  <primary_completion_date type="Actual">November 8, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Airway Volume (iVaw) using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Airway Resistance (iRaw) using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specific Airway Volume (siVaw) using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specific Airway Resistance (siRaw) using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lobe Volumes (iVlobes) using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Air Trapping using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Internal Lobar Airflow Distribution using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Low attenuation or Emphysema Score using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Vessel Density or Fibrosis Score using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Airway Wall Thickness using FRI</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Bronchiolitis Obliterans</condition>
  <condition>Lung Transplant Rejection</condition>
  <arm_group>
    <arm_group_label>HRCT scans</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HRCT scan will be taken</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>High Resolution Computed Tomography scans</intervention_name>
    <description>A HRCT scan at Functional Residual Capacity (FRC) and Total Lung Capacity (TLC) will be taken on visit 1, visit 2, visit 3, visit 4 and visit 5.
An Upper Airway (UA) scan will be taken on visit 1.</description>
    <arm_group_label>HRCT scans</arm_group_label>
    <other_name>HRCT scan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patient â‰¥ 18 years old

          -  Written informed consent obtained

          -  Patient who had undergone a lung transplant a year ago or more

          -  Female patient of childbearing potential who confirm that a contraception method was
             used at least 14 days before screening visit and will continue to use a contraception
             method during the study

          -  The patient must be able to perform the lung monitoring at home

          -  Patients diagnosed with BOS 0, BOS 0-p or BOS 1

        Exclusion Criteria:

          -  Pregnant or lactating female

          -  Known history of or active airways or anastomotic complications requiring intervention
             such as stenting or dilation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilfried De Backer, M.D., M.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Antwerp</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Antwerp University Hospital</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2015</study_first_submitted>
  <study_first_submitted_qc>May 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HRCT</keyword>
  <keyword>High Resolution Computed Tomography scans</keyword>
  <keyword>Functional Respiratory Imaging</keyword>
  <keyword>FRI</keyword>
  <keyword>Computed Tomography</keyword>
  <keyword>CT</keyword>
  <keyword>Bronchiolitis Obliterans Syndrome</keyword>
  <keyword>BOS</keyword>
  <keyword>Lung Transplant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Bronchiolitis Obliterans</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

